Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Welch

Showing results (11-20 of 30) with videos related to

Pageof 3
Sort By:
Journal of the American College of Cardiology|August 15, 2020
Reply: Hemorrhagic Stroke, All-Cause Death, and Intensive LDL-C Lowering: Evidence From SPARCL and BeyondMichael Szarek, Pierre Amarenco, Alfred Callahan, et al.
ACS Nano|June 14, 2012
Evaluating the pharmacokinetics and in vivo cancer targeting capability of Au nanocages by positron emission tomography imagingYucai Wang, Yongjian Liu, Hannah Luehmann, et al.
Veterinary Sciences|January 20, 2023
Characterization of Two Porcine Parainfluenza Virus 1 Isolates and Human Parainfluenza Virus 1 Infection in Weaned Nursery PigsMichael Welch, Karen Krueger, Jianqiang Zhang, et al.
Genome Announcements|October 21, 2017
Complete Genome Sequence of <i>Porcine respirovirus 1</i> Strain USA/MN25890NS/2016, Isolated in the United StatesJie Yeun Park, Michael Welch, Karen M Harmon, et al.
Health Promotion Practice|November 13, 2003
Engaging high-risk populations in community-level fitness promotion: ROCK! RichmondAntronette K Yancey, Audrey Jordan, Judith Bradford, et al.
Stroke|October 11, 2008
Atorvastatin reduces the risk of cardiovascular events in patients with carotid atherosclerosis: a secondary analysis of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trialHenrik Sillesen, Pierre Amarenco, Michael G Hennerici, et al.
Hellenic Journal of Nuclear Medicine|September 17, 2013
Carbon-11-acetate positron emission tomography (PET), versus fluorine- 18 fluorodeoxyglucose PET and CT for the diagnosis of recurrent prostate cancer after radical prostatectomy in cases of prostate specific antigen of more than 1 to 3ng/mLNobuyuki Oyama, Hideaki Ito, Yoshitaka Aoki, et al.
Journal of the American College of Cardiology|March 21, 2020
Atorvastatin Reduces First and Subsequent Vascular Events Across Vascular Territories: The SPARCL TrialMichael Szarek, Pierre Amarenco, Alfred Callahan, et al.
BMC Veterinary Research|March 22, 2022
Detection of porcine parainfluenza virus type-1 antibody in swine serum using whole-virus ELISA, indirect fluorescence antibody and virus neutralizing assaysMichael Welch, Karen Krueger, Jianqiang Zhang, et al.
Virology|September 9, 2021
Pathogenesis of a novel porcine parainfluenza virus type 1 isolate in conventional and colostrum deprived/caesarean derived pigsMichael Welch, Jie Park, Karen Harmon, et al.
Pageof 3

Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
Journal of the American College of Cardiology|August 15, 2020
Reply: Hemorrhagic Stroke, All-Cause Death, and Intensive LDL-C Lowering: Evidence From SPARCL and BeyondMichael Szarek, Pierre Amarenco, Alfred Callahan, et al.
ACS Nano|June 14, 2012
Evaluating the pharmacokinetics and in vivo cancer targeting capability of Au nanocages by positron emission tomography imagingYucai Wang, Yongjian Liu, Hannah Luehmann, et al.
Veterinary Sciences|January 20, 2023
Characterization of Two Porcine Parainfluenza Virus 1 Isolates and Human Parainfluenza Virus 1 Infection in Weaned Nursery PigsMichael Welch, Karen Krueger, Jianqiang Zhang, et al.
Genome Announcements|October 21, 2017
Complete Genome Sequence of <i>Porcine respirovirus 1</i> Strain USA/MN25890NS/2016, Isolated in the United StatesJie Yeun Park, Michael Welch, Karen M Harmon, et al.
Health Promotion Practice|November 13, 2003
Engaging high-risk populations in community-level fitness promotion: ROCK! RichmondAntronette K Yancey, Audrey Jordan, Judith Bradford, et al.
Stroke|October 11, 2008
Atorvastatin reduces the risk of cardiovascular events in patients with carotid atherosclerosis: a secondary analysis of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trialHenrik Sillesen, Pierre Amarenco, Michael G Hennerici, et al.
Hellenic Journal of Nuclear Medicine|September 17, 2013
Carbon-11-acetate positron emission tomography (PET), versus fluorine- 18 fluorodeoxyglucose PET and CT for the diagnosis of recurrent prostate cancer after radical prostatectomy in cases of prostate specific antigen of more than 1 to 3ng/mLNobuyuki Oyama, Hideaki Ito, Yoshitaka Aoki, et al.
Journal of the American College of Cardiology|March 21, 2020
Atorvastatin Reduces First and Subsequent Vascular Events Across Vascular Territories: The SPARCL TrialMichael Szarek, Pierre Amarenco, Alfred Callahan, et al.
BMC Veterinary Research|March 22, 2022
Detection of porcine parainfluenza virus type-1 antibody in swine serum using whole-virus ELISA, indirect fluorescence antibody and virus neutralizing assaysMichael Welch, Karen Krueger, Jianqiang Zhang, et al.
Virology|September 9, 2021
Pathogenesis of a novel porcine parainfluenza virus type 1 isolate in conventional and colostrum deprived/caesarean derived pigsMichael Welch, Jie Park, Karen Harmon, et al.
Pageof 3